New drug cocktail aims to wipe out bladder cancer before surgery
Disease control
Recruiting now
This phase 3 trial tests whether combining the targeted drug disitamab vedotin (RC48) with chemotherapy (gemcitabine) before surgery works as well as RC48 plus an immunotherapy (toripalimab) for people with HER2-positive muscle-invasive bladder cancer. Participants receive one of…
Phase: PHASE3 • Sponsor: Zhiquan Hu • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC